SMAD3 and renal fibrosis: In addition, inhibition of TGF-β/Smad3-mediated renal fibrosis by overexpressing renal Smad7 in the established chronic AAN further supported the inhibitory role of Smad7 in progressive chronic AAN and may also well explain the therapeutic effect of Smad7 on chronic AAN.